NCT02243943View on ClinicalTrials.gov

Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Postoperative Respiratory Condition
Interventions
DRUG

Sugammadex

DRUG

Neostigmine

Trial Locations (1)

2333ZA

Leiden Medical University, Leiden

All Listed Sponsors
lead

Leiden University Medical Center

OTHER

NCT02243943 - Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile | Biotech Hunter | Biotech Hunter